Is RLAY a buy or a sell?
The Discounted Cash Flow (DCF) valuation of Relay Therapeutics Inc (RLAY) is (64.29) USD. With the latest stock price at 3.10 USD, the upside of Relay Therapeutics Inc based on DCF is -2173.8%. This means that RLAY is a sell according to the DCF valuation model.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 5.8% - 7.5% | 6.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (198.13) - (39.47) | (64.29) |
| Upside | -6491.2% - -1373.4% | -2173.8% |